CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 72 enrolled
Drug / intervention
Lidocaine Gel (2%) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02852434
NCT02852434Phase 3Completed
CompareCT.gov

Self-administered Lidocaine Gel for Pain-control During Cervical Preparation for Dilation and Evacuation: A Randomized Controlled Trial

Stanford University·interventional·Posted Aug 2, 2016·Updated Jun 7, 2019

In Brief

A Phase 3 clinical trial evaluating Lidocaine Gel (2%) and Lidocaine Paracervical Block (1%) for Pain Management, Cervical Preparation. Completed, enrolled 72 participants across 1 site.

Detailed Summary

This study seeks to compare self-administered lidocaine gel for pain control during cervical preparation for dilation and evacuation (D\&E) to paracervical block.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain Management, Cervical Preparation
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2017201820192020202120222023202420252026
First PostedAug 2, 2016
Enrollment StartJul 1, 2016
Primary CompletionApr 1, 2017
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 9.9 years ago

Interventions

Lidocaine Gel (2%)drug

Lidocaine Paracervical Block (1%)drug